• FAQs
  • Glossary
Close

FAQs

Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

See all FAQs

Close

Glossary

Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial

See full Glossary

Resources

Search within the page or choose from the most common topics below

Theme
Condition
arm logo

ARM Project A-Gene

abpi_pharmacovigilance

ABPI Guidance notes on the management of safety information and product complaints from digital activities

abpi logo

ABPI Establishing payment models that support timely access to ATMPs

pre_to_clinical

ABPI Bridging between pre- and clinical boundary

abpi health data

ABPI Health Data

abpi logo

ABPI Animals and Medicines Research

ABPI logo

ABPI Guidelines for Phase I Clinical Trials

ABPI

ABPI ATMP Roadmap

ATMP_Sweden_logo

ATMP Sweden Commercial Guide

ATMP Sweden logo

ATMP Sweden: What are ATMPs?

English ATMP Sweden logo

ATMP Sweden GMP Checklist

English ATMP_Sweden_logo

ATMP Sweden Regulatory Guide

attc_HTA_guide

ATTC Health Technology Assessment (HTA) Guide

attc_ manufacturing_toolkit

ATTC Manufacturing and Preparation Toolkit

EuroGCT Resource

Case Study: Holoclar

dna

Research and Innovation Binding Text and Guidance

dna

Commercialisation Binding Text and Guidance

Therapy Classification Binding Text and Guidance

dna

Manufacturing Binding Text and Guidance

dna

Health Data Binding Text

Back to top